Tag: ad

行競科技攜手聯邦國際租賃打造車規等級儲能租賃方案

唯一台灣自研浸沒式冷卻系統 × 長期穩健金融夥伴助攻企業實現永續轉型

唯一台灣自研浸沒式冷卻系統 × 長期穩健金融夥伴 助攻企業實現永續轉型

SIKA ACHIEVES GLOBAL GROWTH OF 1.6% IN LOCAL CURRENCIES AND EXPANDS ITS PROFIT MARGIN

Ad Hoc announcement pursuant to Article 53 of the Listing Rules of the SIX Exchange Regulation

Alpha-synuclein Inhibitors Market to Witness Strong CAGR Through 2034, Driven by Advances in Neurodegenerative Therapies | DelveInsight

No alpha-synuclein inhibitors are approved, underscoring a major need for therapies that slow or halt Parkinson's progression. Developing safe, brain-penetrant drugs that target toxic...

Qynapse Releases Data Highlighting the Accuracy of QyScore® and Predictive performance of QyPredict® for Disease Progression in preclinical Alzheimer’s Disease

TORONTO, July 28, 2025 /PRNewswire/ -- Qynapse, a technology company using AI to enhance the quantification and predictive capabilities of imaging to improve outcomes for...

Warner Bros. Discovery Announces Post-Separation Company Names and Leadership Appointments

"Streaming & Studios" Company will be Warner Bros.; "Global Networks" Company will be Discovery Global NEW YORK, July 28, 2025 /PRNewswire/ -- Warner Bros. Discovery...

REITIR: Framkvæmd endurkaupaáætlunar í viku 30

Stjórn Reita fasteignafélags hf. samþykkti nýja endurkaupaáætlun félagsins þann 1. júlí 2025 sbr. tilkynningu í Kauphöll þann dag. Var henni hrint í framkvæmd þann 2. júlí 2025. Endurkaupaáætlunin er framkvæmd í samræmi við ákvæði hlutafélagalaga nr. 2/1995, 5. gr. reglugerðar Evrópuþingsins og ráðsins (ESB) um markaðssvik nr. 596/2014, sem og framselda reglugerð framkvæmdastjórnarinnar 2016/1052, samanber lög um aðgerðir gegn markaðssvikum nr. 60/2021.

Alamar Biosciences Showcases Pioneering Brain-Derived pTau Data at the Alzheimer’s Association International Conference (AAIC)

Groundbreaking Insights into Neurodegenerative Disease Biomarkers to be Unveiled through 30+ Posters and Presentations at International Meeting FREMONT, Calif., July 28, 2025 /PRNewswire/ -- Alamar...

NKGen Biotech Presents Troculeucel Mechanism of Action with Corresponding Phase 1 Biomarker Data at the Alzheimer’s Association International Conference 2025

SANTA ANA, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer (“NK”) cell therapeutics, today announced the presentation of a poster entitled, “Mechanism of Action of Troculeucel (Non-genetically Modified Natural Killer Cells with Enhanced Cytotoxicity) in Alzheimer's Disease Confirmed by Corresponding Phase I Biomarker Data” at the Alzheimer’s Association International Conference 2025 (“AAIC 2025”) held in Toronto, Canada and online from July 27-31, 2025.

T1 Energy Strategy Supported by Section 232 Polysilicon and AD/CVD Investigations

T1 Energy Strategy Supported by Section 232 Polysilicon and AD/CVD Investigations. T1's contract for U.S. made polysilicon is a competitive advantage.

Kaldalón hf.: Reglubundin tilkynning um kaup á eigin bréfum í samræmi við endurkaupaáætlun

Í viku 30 árið 2025 keypti Kaldalón hf. 541.917 eigin hluti að kaupvirði kr. 13.732.770 skv. sundurliðun hér á eftir;

Nova Klúbburinn hf.: Framkvæmd endurkaupaáætlunar í viku 30

Í 30. viku 2025 keypti Nova Klúbburinn hf. 2.400.000 eigin hluti að kaupverði 11.700.000 kr. í samræmi við eftirfarandi:

Síminn hf. – Reglubundin tilkynning um kaup á eigin bréfum í samræmi við endurkaupaáætlun

Í 30. viku 2025 keypti Síminn hf. 4.000.000 eigin hluti að kaupverði 54.600.000 kr. skv. sundurliðun hér á eftir:

Roche presents new insights in Alzheimer’s disease research across its diagnostics and pharmaceutical portfolios at AAIC

Basel, 28 July 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that new data from its Alzheimer’s development portfolio is being presented at the Alzheimer’s Association International Conference (AAIC) in Toronto, Canada (July 27-30). These data exemplify the comprehensive approach Roche is taking in addressing Alzheimer’s across the entire patient journey.

號召全球粉絲共慶大熊貓龍鳳胎一歲生日全城繽紛活動與生日特別版LABUBU x Panda Twins 幸運抽獎等你參加

為期一個月的非凡生日慶典，當中滿載驚喜連連的熊貓主題活動、話題打卡時刻，還有贏取限量版LABUBU x Panda Twins的珍貴機會

為期一個月的非凡生日慶典，當中滿載驚喜連連的熊貓主題活動、話題打卡時刻，還有贏取限量版LABUBU x Panda Twins的珍貴機會

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Company Name

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Name

This field is for validation purposes and should be left unchanged.

HomeTagsAd

Marler Clark Urges Parents to Stop Using Nara Organics Whole Milk Organic Powdered Infant Formula Amid Multistate Infant Botulism Outbreak — Product Sold Nationwide...

First-Ever Edie Harper Tile Collection Debuts at Motawi Tileworks

ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages GRAIL, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GRAL